Spots Global Cancer Trial Database for mononucleosis
Every month we try and update this database with for mononucleosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection | NCT00575185 | Infectious Mono... | Valomaciclovir placebo | 15 Years - | University of Minnesota | |
| Early Detection of Epstein-Barr Virus Related Disease. | NCT03546101 | Post-transplant... Mononucleosis Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Hemophagocytic ... Hemophagocytosi... | - | University of Aarhus | ||
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults | NCT05164094 | Epstein-Barr Vi... | mRNA-1189 Placebo | 12 Years - 30 Years | ModernaTX, Inc. | |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Adults | NCT05831111 | Epstein-Barr Vi... | mRNA-1195.1 mRNA-1195.2 mRNA-1189 Placebo | 18 Years - 55 Years | ModernaTX, Inc. | |
| Early Detection of Epstein-Barr Virus Related Disease. | NCT03546101 | Post-transplant... Mononucleosis Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Hemophagocytic ... Hemophagocytosi... | - | University of Aarhus | ||
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Adults | NCT05831111 | Epstein-Barr Vi... | mRNA-1195.1 mRNA-1195.2 mRNA-1189 Placebo | 18 Years - 55 Years | ModernaTX, Inc. | |
| Genetic Studies of Chronic Active Epstein-Barr Disease | NCT00032513 | Chronic Active ... | 1 Year - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults | NCT05164094 | Epstein-Barr Vi... | mRNA-1189 Placebo | 12 Years - 30 Years | ModernaTX, Inc. | |
| Genetic Studies of Chronic Active Epstein-Barr Disease | NCT00032513 | Chronic Active ... | 1 Year - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) | NCT05473325 | Diabetes Chronic Kidney ... Cancer Bowel Disease Cardiovascular ... Mononucleosis Flu Heart Diseases HIV Infections AIDS and Infect... Bulimia Chest Infection... Arthritis Leukaemia Alcoholic Liver... Allergies Alzheimer Disea... Appendicitis Eczema Bronchitis Cellulitis Cirrhosis Depression Gout High Cholestero... Indigestion Obesity Osteoporosis | 18 Years - | Willows Health | ||
| Early Detection of Epstein-Barr Virus Related Disease. | NCT03546101 | Post-transplant... Mononucleosis Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Epstein-Barr Vi... Hemophagocytic ... Hemophagocytosi... | - | University of Aarhus |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
